Results
Mahamaya Lifesciences H1 FY27 Revenue Up 29.8%
Mahamaya Lifesciences reported H1 FY27 consolidated revenue growth of 29.78% YoY to ₹211.63 crore with PAT up 38% to ₹11.55 crore.
The company is expanding manufacturing capacity with ₹30 crore techni